Most Read Articles
6 days ago
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
5 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
3 days ago
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.
Pearl Toh, 4 days ago
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.

Lifestyle interventions confer benefits for GI symptoms in irritable bowel syndrome

15 Nov 2017

Both hatha yoga and a low-FODMAP (Fermentable, Oligo-, Di-, Monosaccharides and Polyol) diet can alleviate gastrointestinal symptoms, as well as improve a range of other psychological and physiological health parameters, in patients with irritable bowel syndrome (IBS), a study has shown.

A total of 59 IBS patients were randomized to a 12-week lifestyle intervention involving either yoga or a low-FODMAP diet. Patients in the yoga group received two sessions weekly, while those in the low-FODMAP group attended a total of three sessions of nutritional counselling.

Change in gastrointestinal symptoms (IBS-SSS) was assessed as the primary outcome. Secondary outcomes included changes in quality of life, health, perceived stress, body awareness, body responsiveness and safety of the interventions. Evaluations were performed at weeks 12 and 24 by assessors “blinded” to patients’ group allocation.

IBS-SSS score did not significantly differ between the two intervention groups at either 12 (Δ, 31.80; 95 percent CI, −11.90 to 75.50; p=0.151) or 24 weeks (Δ, 33.41; −4.21 to 71.04; p=0.081), but within group comparisons revealed statistically significant effects for yoga and low-FODMAP diet at both time points (p<0.001 for all).

Effects for the other outcomes were comparable between the yoga and low-FODMAP diet groups. Serious and nonserious adverse events each occurred in one patient in both intervention groups.

Researchers pointed out that both interventions offer promising, safe treatments for patients with IBS. However, more research is needed to evaluate the long-term effects, cost-effectiveness and efficacy of hatha yoga and a low-FODMAP diet in comparison with other treatment modalities.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
5 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
3 days ago
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.
Pearl Toh, 4 days ago
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.